Epigenotypes of Latent Herpesvirus Genomes

  • J. MinarovitsEmail author
Part of the Current Topics in Microbiology and Immunology book series (CT MICROBIOLOGY, volume 310)


Epigenotypes are modified cellular or viral genotypes which differ in transcriptional activity in spite of having an identical (or nearly identical) DNA sequence. Restricted expression of latent, episomal herpesvirus genomes is also due to epigenetic modifications. There is no virus production (lytic viral replication, associated with the expression of all viral genes) in tight latency. In vitro experiments demonstrated that DNA methylation could influence the activity of latent (and/or crucial lytic) promoters of prototype strains belonging to the three herpesvirus subfamilies (α-, β-, and γ-herpesviruses). In vivo, however, DNA methylation is not a major regulator of herpes simplex virus type 1 (HSV-1, a human α-herpesvirus) latent gene expression in neurons of infected mice. In these cells, the promoter/enhancer region of latency-associated transcripts (LATs) is enriched with acetyl histone H3, suggesting that histone modifications may control HSV-1 latency in terminally differentiated, quiescent neurons. Epstein-Barr virus (EBV, a human γ-herpesvirus) is associated with a series of neoplasms. Latent, episomal EBV genomes are subject to host cell-dependent epigenetic modifications (DNA methylation, binding of proteins and protein complexes, histone modifications). The distinct viral epigenotypes are associated with distinct EBV latency types, i.e., cell type-specific usage of latent EBV promoters controlling the expression of latent, growth transformation-associated EBV genes. The contribution of major epigenetic mechanisms to the regulation of latent EBV promoters is variable. DNA methylation contributes to silencing of Wp and Cp (alternative promoters for transcripts coding for the nuclear antigens EBNA 1–6) and LMP1p, LMP2Ap, and LMP2Bp (promoters for transcripts encoding transmembrane proteins). DNA methylation does not control, however, Qp (a promoter for EBNA1 transcripts only) in lymphoblastoid cell lines (LCLs), although in vitro methylated Qp-reporter gene constructs are silenced. The invariably unmethylated Qp is probably switched off by binding of a repressor protein in LCLs.


Barr Virus Latent Membrane Protein Herpes Simplex Thymidine Kinase Gene Barr Virus Latent Membrane Protein 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. Adam GIR, Cui H, Miller SJ, Flam F, Ohlsson R (1996) Allele-specific in situ hybridization (ASISH) analysis: a novel technique which resolves differential usage of H19 within the same cell lineage during human placental development. Development 122:839–847PubMedGoogle Scholar
  2. Adams A, Lindahl T (1975) Epstein-Barr virus genomes with properties of circular DNA molecules in carrier cells. Proc Natl Acad Sci USA 72:1477–1481PubMedCrossRefGoogle Scholar
  3. Alcobia I, Dilao R, Parreira L (2000) Spatial associations of centromers in the nuclei of hematopoietic cells: evidence for cell-type-specific organizational patterns. Blood 95:1608–1615PubMedGoogle Scholar
  4. Altiok E, Minarovits J, Hu LF, Contreras-Brodin B, Klein G, Ernberg I (1992) Host-cell-phenotype-dependent control of BCR2/BWR1 promoter complex regulates the expression of Epstein-Barr virus antigens 2–6. Proc Natl Acad Sci USA 89:905–909PubMedCrossRefGoogle Scholar
  5. Arthur JL, Scarpini CG, Connor V, Lachmann RH, Tolkowsky AM, Efstathiou S (2001) Herpes simplex virus type 1 promoter activity during latency establishment, maintenance, and reactivation in primary dorsal root neurons in vitro. J Virol 75:3885–3895PubMedCrossRefGoogle Scholar
  6. Bednarik DP (1996) The silencing of human immunodeficiency virus. In: Russo EA, Martienssen RA, Riggs AD (eds) Epigenetic mechanisms of gene regulation. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, pp 547–559Google Scholar
  7. Bhende P, Seaman W, Delecluse HJ, Kenney SC (2004) The EBV lytic switch protein Z, preferentially binds to and activates the methylated viral genome. Nat Genet 36:1099–1104PubMedCrossRefGoogle Scholar
  8. Brooks AR, Harkins RN, Wang P, Qian HS, Liu P, Rubanyi GM (2004) Transcriptional silencing is associated with extensive methylation of the CMV promoter following adenoviral gene delivery to muscle. J Gene Med 6:395–404PubMedCrossRefGoogle Scholar
  9. Brown KE, Guest SS, Smale ST, Hahm K, Merkenschlager M, Fischer A (1997) Association of transcriptionally silent genes with Ikaros complexes at centromeric heterochromatin. Cell 91:845–854PubMedCrossRefGoogle Scholar
  10. Buschhausen G, Graessmann M, Graessmann A (1985) Inhibition of herpes simplex thymidine kinase gene expression by DNA methylation is an indirect effect. Nucleic Acids Res 13:5503–5513PubMedGoogle Scholar
  11. Buschhausen G, Wittig B, Graessmann M, Graessmann A (1987) Chromatin structure is required to block transcription of the methylated herpes simplex thymidine kinase gene. Proc Natl Acad Sci USA 84:1177–1181PubMedCrossRefGoogle Scholar
  12. Chau CM, Lieberman PM (2004) Dynamic chromatin boundaries delineate a latency control region of Epstein-Barr virus. J Virol 78:12308–12319PubMedCrossRefGoogle Scholar
  13. Chen F, Hu LF, Ernberg I, Klein G, Winberg G (1995) Coupled transcription of Epstein-Barr virus latent membrane protein (LMP)-1 and LMP2-B genes in nasopharyngeal carcinomas. J Gen Virol 76:131–138PubMedGoogle Scholar
  14. Chen HL, Lung MM, Sham JS, Choy DT, Griffin BE, Ng MH (1992) Transcription of BamHI-A region of the EBV genome in NPC tissues and B cells. Virology 191:193–201PubMedCrossRefGoogle Scholar
  15. Chen J, Ueda K, Sakakibara S, Okuno T, Parravicini C, Corbellino M, Yamanishi K (2001) Activation of latent Kaposi’s sarcoma-associated herpesvirus by demethylation of the promoter of the lytic transactivator. Proc Natl Acad Sci USA 98:4119–4124PubMedCrossRefGoogle Scholar
  16. Christy B, Scangos G (1982) Expression of transfected thymidine kinase genes is controlled by methylation. Proc Natl Acad Sci USA 79:6299–6303PubMedCrossRefGoogle Scholar
  17. Contreras-Brodin BA, Anvret M, Imreh S, Altiok E, Klein G, Masucci MG (1991) Bcellphenotype-dependent expression of the Epstein-Barrvirus nuclear antigens EBNA2-to EBNA-6: studies with somatic cell hybrids. J Gen Virol 72:3025–3033PubMedGoogle Scholar
  18. de Jesus O, Smith PR, Spender LC, Karstegl CE, Niller HH, Huang D, Farrell PJ (2003) Updated Epstein-Barr virus (EBV) DNA sequence and analysis of a promoter for the BART (CST, BARF0) RNAs of EBV. J Gen Virol 84:1443–1450PubMedCrossRefGoogle Scholar
  19. Decaussin G, Sbih-Lammali F, de Turenne-Tessier M, Bouguermouh A, Ooka T (2000) Expression of BARF 1 gene encoded by Epstein-Barr virus in nasopharyngeal carcinoma biopsies. Cancer Res 60:5584–5588PubMedGoogle Scholar
  20. Deshamne SL, Fraser NW (1989) During latency, herpes simplex virus type 1 DNA is associated with nucleosomes in a chromatin structure. J Virol 63:943–947Google Scholar
  21. Desrosiers RC (1982) Specifically unmethylated cytidylic-guanylate sites in herpesvirus saimiri DNA in tumor cells. J Virol 43:427–435PubMedGoogle Scholar
  22. Desrosiers RC, Mulder C, Fleckenstein B (1979) Methylation of herpesvirus saimiri DNA in lymphoid tumor cell lines. Proc Natl Acad Sci USA 76:3839–3843PubMedCrossRefGoogle Scholar
  23. Dobson AT, Sedarati F, Devi-Rao G, Flanagan WM, Farrell MJ, Stevens JG, Wagner EK, Feldman LT (1989) Identification of the latency-associated transcript promoter by expression of beta-globin mRNA in mouse sensory nerve ganglia latently infected with a recombinant herpes simplex virus. J Virol 63:3844–3851PubMedGoogle Scholar
  24. Dressler GR, Rock DL, Fraser NW (1987) Latent herpes simplex virus type I DNA is not extensively methylated in vivo. J Gen Virol 68:1761–1765PubMedGoogle Scholar
  25. Egger G, Liang G, Jones P (2004) Epigenetics in human disease and prospects for epigenetic therapy. Nature 429:457–463PubMedCrossRefGoogle Scholar
  26. Ehrlich M (2003) Expression of various genes is controlled by DNA methylation during mammalian development. J Cell Biochem 88:899–910PubMedCrossRefGoogle Scholar
  27. Elliott J, Goodhew EB, Krug LT, Shakhnovsky N, Yoo L, Speck SH (2004) Variable methylation of the Epstein-Barr virus Wp EBNA gene promoter in B-lymphoblastoid cell lines. J Virol 78:14602–14605Google Scholar
  28. Falk KI, Szekely L, Aleman A, Ernberg I (1998) Specific methylation patterns in two control regions of Epstein-Barr virus latency: the LMP1-coding upstream regulatory region and an origin of DNA replication (oriP). J Virol 72:2969–2974PubMedGoogle Scholar
  29. Forejt J, Saam JR, Gregorova S, Tilgham SM (1999) Monoallelic expression of reactivated imprinted genes in embryonal carcinoma cell hybrids. Exp Cell Res 252:416–422PubMedCrossRefGoogle Scholar
  30. Frommer M, McDonald LE, Millar DS, Collis CM, Watt F, Grigg GW, Molloy PL, Paul CL (1992) A genomic sequencing protocol that yields a positive display of 5-methylcytosine residues in individual DNA strands. Proc Natl Acad Sci USA 89:1827–1831PubMedCrossRefGoogle Scholar
  31. Honess RW, Gompels UA, Barrell BG, Craxton M, Cameron KR, Staden R, Chang YN, Hayward GS (1989) Deviations from expected frequencies of CpG dinucleotides in herpesvirus DNAs may be diagnostic of differences in the states of their latent genomes. J Gen Virol 70:837–855PubMedGoogle Scholar
  32. Hu LF, Minarovits J, Contreras-Salazar B, Rymo L, Falk K, Klein G, Ernberg I (1991) Variable expression of latent membrane protein in nasopharyngeal carcinoma can be related to methylation status of the Epstein-Barr virus BNLF-1 5′ flanking region. J Virol 65:1558–1567PubMedGoogle Scholar
  33. Imai S, Koizumi S, Sugiura M, Tokunaga M, Uemura Y, Yamamoto N, Tanaka S, Sato E, Osato T (1994) Gastric carcinoma: monoclonal epithelial malignant cells expressing Epstein-Barr virus latent infection protein. Proc Natl Acad Sci USA 91:9131–9135PubMedCrossRefGoogle Scholar
  34. Jaenisch R, Schnieke A, Harbers K (1985) Treatment of mice with 5-azacytidine activates silent retroviral genomes in different tissues. Proc Natl Acad Sci USA 82:1451–1455PubMedCrossRefGoogle Scholar
  35. Jankelevich S, Kolman JL, Bodnar JW, Miller G (1992) A nuclear attachment region organizes the Epstein-Barr viral plasmid in Raji cells into a single DNA domain. EMBO J 11:1165–1176PubMedGoogle Scholar
  36. Jansson A, Masucci M, Rymo L (1992) Methylation at discrete sites within the enhancer region regulate the activity of the Epstein-Barrvirus BamJI W promoter in Burkitt lymphoma lines. J Virol 66:62–69PubMedGoogle Scholar
  37. Jenuwein T, Allis CD (2001) Translating the histone code. Science 293:2889–2897CrossRefGoogle Scholar
  38. Jin XW, Speck SH (1992) Identification of critical cis elements involved in mediating Epstein-Barr virus nuclear antigen 2-dependent activity of an enhancer located upstream of the viral BamHI C promoter. J Virol 66:2846–2852PubMedGoogle Scholar
  39. Kanamori A, Ikuta K, Shigeharu U, Kato S, Hirai K (1987) Methylation of Marek’s disease virus DNA in chicken T-lymphoblastoid cell lines. J Gen Virol 68:1485–1490PubMedGoogle Scholar
  40. Kerr BM, Lear AL, Rowe M, Croom-Carter D, Young LS, Rookes S, Gallimore PH, Rickinson AB (1992) Three transcriptionally distinct forms of Epstein-Barr virus latency in somatic cell hybrids: cell phenotype dependence of promoter usage. Virology 187:189–201PubMedCrossRefGoogle Scholar
  41. Klein G (1996) EBV-B cell interactions: immortalization, rescue from apoptosis, tumorigenicity. Acta Microbiol Immunol Hung 43:97–105PubMedGoogle Scholar
  42. Kosak ST, Skok JA, Medina KL, Riblet R, Le Beau MM, Fischer AG, Singh H (2002) Subnuclear compartmentalization of immunoglobulin loci during lymphocyte development. Science 296:158–162PubMedCrossRefGoogle Scholar
  43. Kubat NJ, Tran RK, McAnany P, Bloom DC (2004a) Specific histone tail modification and not DNA methylation is a determinant of herpes simplex virus type 1 latent gene expression. J Virol 78:1139–1149PubMedCrossRefGoogle Scholar
  44. Kubat NJ, Amelio AL, Giordani NV, Bloom DC (2004b) The herpes simplex virus type 1 latency-associated transcript (LAT) enhancer/rcr is hyperacetylated during latency independently of LAT transcription. J Virol 78:12508–12518PubMedCrossRefGoogle Scholar
  45. Levine SS, King IF, Kingston RE (2004) Division of labour in Polycomb group repression. Trends Biochem Sci 29:479–485CrossRefGoogle Scholar
  46. Li H, Minarovits J (2003) Host cell-dependent expression of latent Epstein-Barr virus genomes: regulation by DNA methylation. Adv Cancer Res 89:133–156PubMedCrossRefGoogle Scholar
  47. Li Q, Peterson KR, Fang X, Stamatoyannopoulos G (2002) Locus control regions. Blood 100:3077–3086PubMedCrossRefGoogle Scholar
  48. Liebowitz D (1998) Pathogenesis of Epstein-Barr virus. In: McCance DJ (ed) Human tumor viruses. ASM Press, Washington, pp 175–199Google Scholar
  49. Ling PD, Hsieh JD, Ruf IK, Rawlins DE, Hayward SD (1994) EBNA-2 upregulation of Epstein-Barr virus promoters and the cellular CD23 promoter utilizes a common targeting intermediate, CBF1. J Virol 68:5375–5383PubMedGoogle Scholar
  50. Lokensgard JR, Bloom DC, Dobson AT, Feldman LT (1994) Long-term promoter activity during herpes simplex virus latency. J Virol 68:7148–7158PubMedGoogle Scholar
  51. Longnecker R (1998) Molecular biology of Epstein-Barr virus. In: McCance DJ (ed) Human tumor viruses. ASM Press, Washington, pp 135–174Google Scholar
  52. Masucci MG, Contreras-Salazar B, Ragnar E, Falk K, Minarovits J, Ernberg I, Klein G (1989) 5-Azacytidine up regulates the expression of Epstein-Barr virus nuclear antigen 2 (EBNA-2) through EBNA-6 and latentmembrane protein in the Burkitt’s lymphoma line Rael. J Virol 63:3135–3141PubMedGoogle Scholar
  53. McGeoch DJ, Davison AJ (1999) The molecular history of herpesviruses. In: Domingo E, Webster R, Holland J (eds) Origin and evolution of viruses. Academic Press, New York, pp 441–465Google Scholar
  54. Mellerick DM, Fraser NW (1987) Physical state of the latent herpes simplex virus genomein amousemodel system: evidence suggesting an episomal state. Virology 158:265–275PubMedCrossRefGoogle Scholar
  55. Minarovits J, Minarovits-Kormuta S, Ehlin-Henriksson B, Falk K, Klein G, Ernberg I (1991) Host cell phenotype-dependent methylation patterns of Epstein-Barr virus DNA. J Gen Virol 72:1591–1599PubMedGoogle Scholar
  56. Minarovits J, Hu LF, Marcsek Z, Minarovits-Kormuta S, Klein G, Ernberg I (1992) RNA polymerase III-transcribed EBER 1 and 2 transcription units are expressed and hypomethylated in the major Epstein-Barr virus carrying cell types. J Gen Virol 73:1687–1692PubMedGoogle Scholar
  57. Minarovits J, Hu LF, Imai S, Harabuchi Y, Kataura A, Minarovits-Kormuta S, Osato T, Klein G (1994) Clonality, expression and methylation patterns of the Epstein-Barr virus genomes in lethal midline granulomas classified as peripheral angiocentric T cell lymphomas. J Gen Virol 75:77–84PubMedGoogle Scholar
  58. Mitsuya K, Sui H, Meguro M, Kugoh H, Jinno Y, Niikawa N, Oshimura M (1997) Paternal expression of WT1 in human fibroblasts and lymphocytes. Hum Mol Genet 6:2243–2246PubMedCrossRefGoogle Scholar
  59. Morimura T, Ohashi K, Sugimoto C, Onuma M (1998) Pathogenesis of Marek’s disease (MD) and possible mechanism of immunity induced by MD vaccine. J Vet Med Sci 60:1–8PubMedCrossRefGoogle Scholar
  60. Niller HH, Salamon D, Takacs M, Uhlig J, Wolf H, Minarovits J (2001) Protein-DNA interaction and CpG methylation at rep*/vIL-10p of latent Epstein-Barr virus genomes in lymphoid cell lines. Biol Chem 382:1411–1419PubMedCrossRefGoogle Scholar
  61. Niller HH, Salamon D, Ilg K, Koroknai A, Banati F, Bäml G, Rücker OL, Schwarzmann F, Wolf H, Minarovits J (2003) The in vivo binding site for oncoprotein c-Myc in the promoter for Epstein-Barr virus (EBV) encoding RNA (EBER) 1 suggests a specific role for EBV in lymphomagenesis. Med Sci Monit 9:HY1–HY9PubMedGoogle Scholar
  62. Niller HH, Salamon D, Rahmann S, Ilg K, Koroknai A, Bánáti F, Schwarzmann F, Wolf H, Minarovits J (2004a) A 30 kb region of the Epstein-Barr virus genome is colinear with the rearranged human immunoglobulin gene loci: implications for a “ping-pong evolution” model for persisting viruses and their hosts. Acta Microbiol Immunol Hung 51:469–484PubMedCrossRefGoogle Scholar
  63. Niller HH, Salamon D, Banati F, Schwarzmann F, Wolf H, Minarovits J (2004b) The LCR of EBV makes Burkitt’s lymphoma endemic. Trends Microbiol 12:495–499PubMedCrossRefGoogle Scholar
  64. Niller HH, Salamon D, Ilg K, Koroknai A, Banati F, Schwarzmann F, Wolf H, Minarovits J (2004c) EBV-associated neoplasms: alternative pathogenetic pathways. Med Hypotheses 62:387–391PubMedCrossRefGoogle Scholar
  65. Nonoyama M, Pagano JS (1972) Separation of Epstein-Barr virus DNA from large chromosomal DNA in non-virus producing cells. Nature 238:169–171CrossRefGoogle Scholar
  66. Obata Y, Kono T (2002) Maternal primary imprinting is established at a specific time for each gene throughout oocyte growth. J Biol Chem 277:5285–5289PubMedCrossRefGoogle Scholar
  67. Prosch S, Stein J, Staak K, Liebenthal C, Volk HD, Kruger DH (1996) Inactivation of the very strong HCMV immediate early promoter by CpG methylation in vitro. Biol Chem Hoppe Seyler 377:195–201PubMedGoogle Scholar
  68. Robertson KD, Hayward SD, Ling PD, Samid D, Ambinder R (1995) Transcriptional activation of the Epstein-Barr virus latency C promoter after 5-azacytidine treatment: evidence that demethylation at a single CpG site is crucial. Mol Cell Biol 15:6150–6159PubMedGoogle Scholar
  69. Sadler RH, Raab-Traub N (1995) The Epstein-Barr virus 3.5-kilobase latent membrane protein mRNA initiates from a TATA-less promoter within the first terminal repeat. J Virol 69:4577–4581PubMedGoogle Scholar
  70. Saitoh S, Buiting K, Rogan PK, Buxton JL, Driscoll DJ, Arnemann J, König R, Malcolm S, Horsthemke B (1996) Minimal definition of the imprinting center and fixation of a chromosome 15q11-13 epigenotype by imprinting mutations. Proc Natl Acad Sci USA 93:7811–7815PubMedCrossRefGoogle Scholar
  71. Salamon D, Takacs M, Myöhänen S, Marcsek Z, Berencsi G, Minarovits J (2000) De novo methylation at nonrandom founder sites 5′ from an unmethylated minimal origin of DNA replication in latent Epstein-Barr virus genomes. Biol Chem 381:95–105PubMedCrossRefGoogle Scholar
  72. Salamon D, Takacs M, Ujvari D Uhlig J, Wolf H, Minarovits J, Niller HH (2001) Protein-DNA binding and CpG methylation at nucleotide resolution of latency-associated promoters Qp, Cp and LMP1p of Epstein-Barr virus. J Virol 75:2584–2596PubMedCrossRefGoogle Scholar
  73. Salamon D, Takacs M, Schwarzmann F, Wolf H, Minarovits J, Niller HH (2003) High-resolution methylation analysis and in vivo protein-DNA binding at the promoter of the viral oncogene LMP2A in B cell lines carrying latent Epstein-Barr virus genomes. Virus Genes 27:57–66PubMedCrossRefGoogle Scholar
  74. Sano M, Kitayama S (1996) Inhibition of nerve growth factor-induced outgrowth of neurites by trichostatin A requires de novo protein synthesis in PC12D cells. Brain Res 742:195–202PubMedCrossRefGoogle Scholar
  75. Santoso B, Ortiz BD, Winoto A (2000) Control of organ-specific demethylation by an element of the T-cell receptor-α locus control region. J Biol Chem 275:1952–1958PubMedCrossRefGoogle Scholar
  76. Schaefer BC, Strominger JL, Speck SH (1997) Host-cell-determined methylation of specific Epstein-Barr virus promoters regulates the choice between distinct viral latency programs. Mol Cell Biol 17:364–377PubMedGoogle Scholar
  77. Sjöblom-Hallén A, Yang W, Jansson A, Rymo L (1999) Silencing the Epstein-Barr virus latent membrane protein 1 gene by the Max-Mad1-mSin3A modulator of chromatin structure. J Virol 73:2983–2993PubMedGoogle Scholar
  78. Stevens JG, Wagner EK, Devi-Rao GB, Cook ML, Feldman LT (1987) RNA complementary to a herpesvirus alpha gene mRNA prominent in latently infected neurons. Science 235:1056–1059PubMedGoogle Scholar
  79. Strockbine LD, Cohen JI, Farrah T, Lyman SD, Wagener F, DuBose R, Armitage SJ, Spriggs MK (1998) The Epstein-Barr virus BARF1 gene encodes a novel, soluble colony-stimulating factor-1 receptor. J Virol 72:4015–4021PubMedGoogle Scholar
  80. Su A, Wiltshire T, Batalov S, Lapp H, Ching K, Block D, Zhang J, Soden R, Hayakawa M, Kreiman G, Cooke M, Walker JR, Hogenesch JB (2004) A gene atlas of the mouse and human protein-encoding transcriptomes. Proc Natl Acad Sci USA 101:6062–6067PubMedCrossRefGoogle Scholar
  81. Sung NS, Kenney S, Gutsch D, Pagano JS (1991) EBNA-2 transactivates a lymphoid specific enhancer in the BamHI-Cpromoter of Epstein-Barr virus. J Virol 65:2164–2169PubMedGoogle Scholar
  82. Sutter D, Doerfler W (1980) Methylation of integrated adenovirus type 12 DNA sequences in transformed cells is inversely correlated with gene expression. Proc Natl Acad Sci USA 77:253–256PubMedCrossRefGoogle Scholar
  83. Takacs M, Myöhänen S, Altiok E, Minarovits J (1998) Analysis of methylation patterns in the regulatory region of the latent Epstein-Barr virus promoter BCR2 by automated fluorescent genomic sequencing. Biol Chem 379:417–422PubMedCrossRefGoogle Scholar
  84. Takacs M, Salamon D, Myöhänen S, Li H, Segesdi J, Ujvari D, Uhlig J, Niller HH, Wolf H, Berencsi G, Minarovits J (2001a) Epigenetics of latent Epstein-Barr virus genomes: high resolution methylation analysis of the bidirectional promoter region of latent membrane protein 1 and 2B genes. Biol Chem 382:699–705PubMedCrossRefGoogle Scholar
  85. Takacs M, Segesdi J, Balog K, Mezei M, Tóth G, Minárovits J (2001b) Relative deficiency in CpG dinucleotides is a widespread but not unique feature of Gammaherpesvirinae genomes. Acta Microbiol Immunol Hung 48:349–357PubMedCrossRefGoogle Scholar
  86. Tao Q, Robertson KD, Manns A, Hildesheim A, Ambinder RF (1998) The Epstein-Barr virus latent promoter Q is constitutively active, hypomethylated and methylation sensitive. J Virol 72:7075–7083PubMedGoogle Scholar
  87. Tao Q, Huang H, Geiman TM, Lim CY, Fu L, Qiu GH, Robertson KD (2002) Defective de novo methylation of viral and cellular DNA sequences in ICF syndrome cells. Hum Mol Genet 11:2091–9102PubMedCrossRefGoogle Scholar
  88. Tasseron-de Jong JG, den Dulk H, van de Putte P, Giphart-Gassler M (1989) De novo methylation is a major event in the inactivation of transfected herpesvirus thymidine kinase genes in human cells. Biochim Biophys Acta 1007:215–223PubMedGoogle Scholar
  89. Tierney RJ, Kirby HE, Nagra JK, Desmond J, Bell AI, Rickinson AB (2000) Methylation of transcription factor binding sites in the Epstein-Barr virus latent cycle promoter Wp coincides with promoter downregulation during virus-induced B-cell transformation. J Virol 74:10468–10479PubMedCrossRefGoogle Scholar
  90. Toth M, Muller U, Doerfler W (1990) Establishment of de novo DNA methylation patterns. Transcription factor binding and non-CpG sequences in an integrated adenovirus promoter. J Mol Biol 214:673–683PubMedCrossRefGoogle Scholar
  91. Vardimon L, Newmann R, Kuhlmann I, Sutter D, Doerfler W (1980) DNA methylation and viral gene expression in adenovirus transformed and infected cells. Nucleic Acids Res 8:2461–2473PubMedGoogle Scholar
  92. Welch HM, Bridges CG, Lyon AM, Griffiths L, Edington N (1992) Latent equid herpesviruses 1 and 4: detection and distinction using the polymerase chain reaction and co-cultivation from lymphoid tissues. J Gen Virol 73:261–268PubMedCrossRefGoogle Scholar
  93. Wettstein FO, Stevens JG (1983) Shope papilloma virus DNA is extensively methylated in non-virus-producing neoplasms. Virology 126:493–504PubMedGoogle Scholar
  94. Whitelaw E, Martin DIK (2001) Retrotransposons as epigenetic mediators of phenotypic variation in mammals. Nat Genet 27:361–365PubMedCrossRefGoogle Scholar
  95. Woisetschlaeger M, Yandava C, Fumarsky L, Strominger J, Speck S (1990) Promoterswitching in Epstein-Barr virus during the initial infection in B lymphocytes. Proc Natl Acad Sci USA 87:1725–1729PubMedCrossRefGoogle Scholar
  96. Wolffe AP, Matzke MA (1999) Epigenetics: regulation through repression. Science 286:481–486PubMedCrossRefGoogle Scholar
  97. Yoshioka M, Kikuta H, Ishiguro N, Ma X, Kobayashi K (2003a) Unique Epstein-Barr virus (EBV) latent gene expression, EBNA promoter usage and EBNA promoter methylation status in chronic active EBV infection. J Gen Virol 84:1133–1140PubMedCrossRefGoogle Scholar
  98. Yoshioka M, Kikuta H, Ishiguro N, Endo R, Kobayashi K (2003b) Latency pattern of Epstein-Barr virus and methylation status in Epstein-Barr virus-associated hemophagocytic syndrome. J Med Virol 70:410–419PubMedCrossRefGoogle Scholar
  99. Youssoufian H, Hammer SM, Hirsch MS, Mulder M (1982) Methylation of the viral genome in an in vitro model of herpes simplex virus latency. Proc Natl Acad Sci USA 79:2207–2210PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 2006

Authors and Affiliations

  1. 1.Microbiological Research GroupNational Center for EpidemiologyBudapestHungary

Personalised recommendations